LakeShore Biopharma Co. L... (LSB)
NASDAQ: LSB
· Real-Time Price · USD
0.83
-0.01 (-0.72%)
At close: Aug 22, 2025, 1:13 PM
LakeShore Biopharma Ltd Cash Flow Statement
Financials in CNY. Fiscal
year is
April - March.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Net Income | -433.47M | -363.13M | -374.22M | -298.46M | -217.51M | -61.17M | 47.28M | 83.21M | 41.44M | -3.83M | -23.56M | -30.24M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 9.8M | 3.51M | 3.59M | 3.51M | 3.51M | -877.54 | -85.64K | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | n/a | n/a | n/a | n/a | 2.05M | 2.48M | 3.2M | -554.21K | -2.6M | -3.04M | -3.75M | n/a |
Other Non-Cash Items | 423.66M | 359.62M | 370.63M | 294.95M | 211.27M | 56.95M | -53.34M | -90.66M | -43.82M | 2.94M | 24.59M | 32.58M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | n/a | n/a | n/a | 2.05M | 2.48M | 3.2M | -554.2K | -2.6M | -3.04M | -3.75M | n/a |
Operating Cash Flow | n/a | n/a | n/a | n/a | -693.96K | -1.74M | -2.95M | -8.01M | -4.98M | -3.93M | -2.72M | 2.34M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | 734.02K | 2.17M | -1.29B | -1.29B | -1.29B | -1.29B |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | 734.02K | 2.17M | -1.29B | -1.29B | -1.29B | -1.29B |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 1.32K | -1.42M | 20.55M | 20.55M | 20.55M | 21.97M |
Financial Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | -739.52K | -2.19M | 1.3B | 1.3B | 1.3B | 1.3B |
Net Cash Flow | n/a | n/a | n/a | n/a | -698.7K | -1.75M | -2.96M | -8.02M | 4.7M | 5.75M | 6.96M | 12.02M |
Free Cash Flow | n/a | n/a | n/a | n/a | -693.96K | -1.74M | -2.95M | -8.01M | -4.98M | -3.93M | -2.72M | 2.34M |